---
title: "Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286411139.md"
description: "Biofrontera Inc., headquartered in Woburn, MA, released its financial results for the three months concluding on March 31, 2026. Specializing in photodynamic therapy (PDT) in dermatology, the biopharmaceutical company traded under the ticker symbol BFRI on the NASDAQ. The report also included a comprehensive business update."
datetime: "2026-05-14T11:32:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286411139.md)
  - [en](https://longbridge.com/en/news/286411139.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286411139.md)
---

# Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

Biofrontera Inc., headquartered in Woburn, MA, released its financial results for the three months concluding on March 31, 2026. Specializing in photodynamic therapy (PDT) in dermatology, the biopharmaceutical company traded under the ticker symbol BFRI on the NASDAQ. The report also included a comprehensive business update.

### Related Stocks

- [BFRI.US](https://longbridge.com/en/quote/BFRI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BFRIW.US](https://longbridge.com/en/quote/BFRIW.US.md)

## Related News & Research

- [Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update | BFRI Stock News](https://longbridge.com/en/news/279798639.md)
- [Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026 | BFRI Stock News](https://longbridge.com/en/news/278449930.md)
- [Transcript: Biomarin Pharmaceutical Q1 2026 Earnings Conference Call](https://longbridge.com/en/news/285127320.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [12:12 ETKROMATID to Present Breakthrough Genomic Integrity Benchmarking at ASGCT 2026, Powering the World's First Genomic Intelligence Platform](https://longbridge.com/en/news/284807394.md)